Klaria Pharma Holding Overview
- Founded
-
2015
- Status
-
Public
- Employees
-
6
- Stock Symbol
-
KLAR
- Investments
-
3
- Share Price
-
$0.30
- (As of Friday Closing)
Klaria Pharma Holding General Information
Description
Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film.
Contact Information
Website
www.klaria.com
Formerly Known As
Annodam AB
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Stock Exchange
STO
Primary Office
- Virdings Allé 2
- 754 50 Uppsala
- Sweden
+46 08-446 00 00
Klaria Pharma Holding Timeline
Klaria Pharma Holding Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.30 | $0.30 | $0.26 - $0.86 | $17.9M | 59.7M | 21.9K | -$0.18 |
Klaria Pharma Holding Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 20,877 | 33,857 | 37,008 | 13,989 |
| Revenue | 0 | 0 | 0 | 446 |
| EBITDA | (8,220) | (4,590) | (3,834) | (1,169) |
| Net Income | (9,697) | (6,234) | (5,579) | (2,378) |
| Total Assets | 9,922 | 13,073 | 16,141 | 10,880 |
| Total Debt | 0 | 3,505 | 1,251 | 1,152 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Klaria Pharma Holding Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Klaria Pharma Holding Patents
Klaria Pharma Holding Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020338697-A1 | Pharmaceutical formulation | Pending | 30-Aug-2019 | 000000000 | |
| CA-3146475-A1 | Pharmaceutical formulation | Pending | 30-Aug-2019 | 000000000 | |
| EP-4021405-A1 | Pharmaceutical formulation | Pending | 30-Aug-2019 | 000000000 | |
| GB-201912505-D0 | Pharmaceutical formulation | Inactive | 30-Aug-2019 | ||
| US-20220280453-A1 | Pharmaceutical formulation | Pending | 30-Aug-2019 | A61K9/006 |
Klaria Pharma Holding Executive Team (5)
Klaria Pharma Holding Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 0ü0000000 | Klaria Pharma Holding | Co-Founder & Chairman | 000 0000 |
Klaria Pharma Holding Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Klaria Pharma Holding Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 06-Mar-2020 | 0000000000 | 000 | Drug Discovery | 00000 000 |
| 0000000000000 | 05-Nov-2019 | 0000000000 | Drug Delivery | 00000 000 | |
| WBC Technologies | 19-Sep-2019 | Merger of Equals | Discovery Tools (Healthcare) | 00000 000 |
Klaria Pharma Holding Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000 000000 000 | Drug Discovery | Taby, Sweden | 0000 |